Cellyan Biotechnology（HKPD.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

公众及其他50.88%
个人与内部人士47.62%
机构投资者1.50%

主要股东

主要股东最新
股东
Liying Wang	43.73%	715.00 万	0.00%	+0	2025/10/06
Jin Tianruyi	3.78%	61.79 万	0.00%	+0	2025/03/31
Sterne Agee Asset Management, Inc.	0.63%	10.23 万	0.38%	+6.29 万	2026/06/30
Jane Street Group, LLC	0.30%	4.91 万	--	+4.91 万	2026/06/30
Hudson River Trading LLC	0.26%	4.18 万	--	+4.18 万	2026/06/30
XTX Markets Limited	0.24%	3.89 万	--	+3.89 万	2026/06/30
Sun Wong LapChairman of the Board	0.11%	1.85 万	0.00%	+0	2025/10/06
Clear Street LLC	0.07%	1.20 万	0.00%	+0	2026/06/30
UBS Asset Management AG	<0.01%	1,081.00	<0.01%	+971.00	2026/06/30
Two Sigma Investments, LP	0.00%	0.00	0.07%	-1.08 万	2026/06/30